Quick Answer
MARAVAI LIFESCIENCES HOLDINGS, INC. reported Long Term Debt of $286.33 million for the year ending 2025.
- MARAVAI LIFESCIENCES HOLDINGS, INC. showed a decrease of -1.4% in Long Term Debt from 2024 to 2025.
- This data is from MARAVAI LIFESCIENCES HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $527.59 million | Q2 2021: $526.58 million | Q3 2021: $525.58 million | Q1 2022: $524.50 million | Q2 2022: $523.66 million | Q3 2022: $522.82 million | Q1 2023: $521.16 million | Q2 2023: $520.34 million | Q3 2023: $519.52 million | Q1 2024: $517.89 million | Q1 2025: $289.50 million | Q2 2025: $288.44 million | Q3 2025: $287.38 million.
- Over the full 8 years of available data (2020 to 2025), MARAVAI LIFESCIENCES HOLDINGS, INC.'s Long Term Debt has declined by 45.8%.
- Historical annual values: Fiscal year 2025: $286.33 million | Fiscal year 2024: $290.49 million | Fiscal year 2024: $516.28 million | Fiscal year 2024: $517.08 million | Fiscal year 2023: $518.71 million | Fiscal year 2022: $522.00 million | Fiscal year 2021: $524.59 million | Fiscal year 2020: $528.61 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: